Skip to content

Clinical trials

Nervous System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Country / region: Canada Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20103
20111
20122
20134
20147
20153
20167
20173
20185
20195
20202
20213
20222
20239
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting11
Terminated11
Active, not recruiting5
Unknown status4
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca4
GlaxoSmithKline3
PTC Therapeutics3
University Health Network, Toronto3
University of British Columbia3
Centre hospitalier de l'Université de Montréal (CHUM)2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
PepGen Inc2
University of Calgary2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases70
Central Nervous System Diseases32
Brain Diseases26
Neurodegenerative Diseases19
Mental Disorders16
Alzheimer Disease12
Dementia12
Neuromuscular Diseases12
Muscular Diseases10
Cerebrovascular Disorders9

Trials

Showing 26 to 50 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.